Ongoing hormone monitoring
Therapy is not a single decision. Testosterone requires periodic laboratory monitoring so a provider can review response, adjust dosing and watch for changes that warrant attention — haematocrit in particular.
What a provider evaluates
- Trough testosterone relative to the dosing interval
- Haematocrit and haemoglobin at defined intervals
- Estradiol where symptoms or prior results indicate
- PSA where age-appropriate
- Blood pressure, lipids and metabolic markers
What treatment may involve
- Dose or interval adjustment following review
- Additional laboratory work between scheduled panels
- Pausing therapy where results indicate it is appropriate
Whether any of these is appropriate is determined by a licensed provider after reviewing your history and laboratory results.
Markers on this panel
What each marker measures and why your provider tracks it.
Questions about ongoing hormone monitoring
How often do I need labs while on testosterone therapy?
Monitoring intervals are set by the treating provider. A common pattern is follow-up bloodwork within the first few months of starting or changing a dose, then periodically thereafter. Haematocrit is monitored throughout because testosterone can raise it, and PSA is monitored where age-appropriate.
Why is haematocrit monitored on testosterone therapy?
Testosterone can increase red blood cell production, which raises haematocrit — the proportion of blood made up of red cells. Because a rise can occur without symptoms, it is tracked with periodic bloodwork rather than by how you feel. If haematocrit rises beyond an acceptable range, a provider may adjust the dose, change the interval, or pause therapy.